Women’s attitude towards routine human platelet antigen-screening in pregnancy: Attitude towards HPA-screening in pregnancy

Abstract

Introduction. Fetal and neonatal alloimmune thrombocytopenia is a potentially

life-threatening disease with excellent preventative treatment available for

subsequent pregnancies. To prevent index cases, the effectiveness of a population-based screening program has been suggested repeatedly. Therefore, we aimed to evaluate women’s attitude towards possible future human platelet antigen-screening in pregnancy. Material and methods. We performed a crosssectional questionnaire study among healthy pregnant women receiving prenatal care in one of seven participating midwifery practices. Attitude was assessed using a questionnaire based on the validated Multidimensional Measurement of Informed Choice model, containing questions assessing knowledge, attitude and intention to participate. Results. A total of 143 of the 220 women (65%) completed and returned the questionnaire. A positive attitude towards human platelet antigen-screening was expressed by 91% of participants, of which 94% was based on sufficient knowledge. Attitude was more likely to be negatively influenced by the opinion that screening can be frightening. Informed choices were made in 87% and occurred significantly less in women from non-European origin, 89% in European women vs. 60% in non-European women (p = 0.03). Conclusions. Pregnant women in the Netherlands expressed a positive attitude towards human platelet antigenscreening in pregnancy. We therefore expect a high rate of informed uptake when human platelet antigen-screening is implemented. In future counseling on human platelet antigen-screening, ethnicity and possible anxiety associated with a screening test need to be specifically addressed.